Da-Wu Zeng (Dawu Zeng)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Topics

Decision Making

Hepatitis B Virus

Top Venues

Alimentary pharmacology & therapeutics

Journal of medical virology

Journal of clinical and translational hepatology

Viral immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Na-Ling Kang, Lu-Ying Wu, Qi Zheng, Xue-Ping Yu, Ai-Rong Hu, Yue Guo, Huan Li, Xiang-Yang Ye, Qing-Fa Ruan, Zhong-Hua Lu, Ling Wu, Wen Jin, Yu-Rui Liu, Chen Pan, Shan-Shan Liu, Ji-Ming Zhang, Jia-Ji Jiang, Da-Wu Zeng
Determining optimal ALT cut-off values for predicting significant hepatic histological changes in patients with normal ALT in the grey zone of chronic hepatitis B virus infection. Alimentary pharmacology & therapeutics 59 (5) (2024)
Na-Ling Kang, Lu-Ying Wu, Qi Zheng, Xue-Ping Yu, Ai-Rong Hu, Yue Guo, Huan Li, Xiang-Yang Ye, Qing-Fa Ruan, Zhong-Hua Lu, Ling Wu, Wen Jin, Yu-Rui Liu, Chen Pan, Shan-Shan Liu, Ji-Ming Zhang, Jia-Ji Jiang, Da-Wu Zeng
Determining optimal ALT cut-off values for predicting significant hepatic histological changes in patients with normal ALT in the grey zone of chronic hepatitis B virus infection. Alimentary pharmacology & therapeutics 59 (5) (2024)
Na-Ling Kang, Lu-Ying Wu, Qi Zheng, Xue-Ping Yu, Ai-Rong Hu, Yue Guo, Huan Li, Xiang-Yang Ye, Qing-Fa Ruan, Zhong-Hua Lu, Ling Wu, Wen Jin, Yu-Rui Liu, Chen Pan, Shan-Shan Liu, Ji-Ming Zhang, Jia-Ji Jiang, Da-Wu Zeng
Determining optimal ALT cut-off values for predicting significant hepatic histological changes in patients with normal ALT in the grey zone of chronic hepatitis B virus infection. Alimentary pharmacology & therapeutics (2024)
Na-Ling Kang, Lu-Ying Wu, Qi Zheng, Xue-Ping Yu, Ai-Rong Hu, Yue Guo, Huan Li, Xiang-Yang Ye, Qing-Fa Ruan, Zhong-Hua Lu, Ling Wu, Wen Jin, Yu-Rui Liu, Chen Pan, Shan-Shan Liu, Ji-Ming Zhang, Jia-Ji Jiang, Da-Wu Zeng
Determining optimal ALT cut-off values for predicting significant hepatic histological changes in patients with normal ALT in the grey zone of chronic hepatitis B virus infection. Alimentary pharmacology & therapeutics 59 (5) (2024)
Na-Ling Kang, Lu-Ying Wu, Qi Zheng, Xue-Ping Yu, Ai-Rong Hu, Yue Guo, Huan Li, Xiang-Yang Ye, Qing-Fa Ruan, Zhong-Hua Lu, Ling Wu, Wen Jin, Yu-Rui Liu, Chen Pan, Shan-Shan Liu, Ji-Ming Zhang, Jia-Ji Jiang, Da-Wu Zeng
Determining optimal ALT cut-off values for predicting significant hepatic histological changes in patients with normal ALT in the grey zone of chronic hepatitis B virus infection. Alimentary pharmacology & therapeutics 59 (5) (2024)
Ling-Ling Huang, Xue-Ping Yu, Qing-Fa Ruan, Yan-Xue Lin, Huan Li, Wen Jin, Rui-Feng Liu, Yan-Lan Liang, Yu-Rui Liu, Yue-Yong Zhu, Jia-Ji Jiang, Ri-Cheng Mao, Da-Wu Zeng
Liver Stiffness Measurement can Predict Liver Inflammation in Chronic Hepatitis B Patients with Normal Alanine Transaminase. Journal of clinical and translational hepatology 11 (4) (2023)
Jie-Min Zhang, Na-Ling Kang, Lu-Ying Wu, Da-Wu Zeng
Hepatitis B Virus Envelope Antigen and Hepatitis B Virus Surface Antigen Both Contribute to the Innate Immune Response During Persistent Hepatitis B Virus Infection. Viral immunology (2023)
Na-Ling Kang, Ya-Hong Gao, Meng-Xin Lin, Lu-Ying Wu, Xiang-Yang Ye, Hui-Ming Lin, Qing-Fa Ruan, Shuo Lin, Hao-Hang Liu, Ling-Ling Huang, Jia-Ji Jiang, Yu-Rui Liu, Qi Zheng, Ri-Cheng Mao, Da-Wu Zeng
Development a novel nomogram model for predicting significant hepatic histological changes in chronic hepatitis B virus carriers. Journal of medical virology 95 (7) (2023)
Na-Ling Kang, Qing-Fa Ruan, De-Sheng Zhang, Xue-Ping Yu, Zhen-Ting Hu, Zhi-Min Lin, Lu-Ying Wu, Meng-Xin Lin, Zu-Xiong Huang, Jia-Ji Jiang, Yu-Rui Liu, Ri-Cheng Mao, Da-Wu Zeng
Advantages of a Novel Model for Predicting Hepatic Fibrosis in Chronic Hepatitis B Virus Carriers Compared with APRI and FIB-4 Scores. Journal of clinical and translational hepatology 10 (3) (2022)
Xue-Ping Yu, Yijuan Zheng, Da-Wu Zeng, Yongjun Zhou, Jian Sun, Milong Su, Huatang Zhang, Minhui Zheng, Zhipeng Huang, Wenwu Lin, Richeng Mao, Qirong Jiang, Chunfu Zheng, Zhijun Su
Decreased frequency of a novel T-lymphocyte subset, CD3 + CD4 - CD7 + CD57 - T cells, in hepatitis B virus-related end-stage liver disease might contribute to disease progression. Journal of medical virology (2022)